Skip to main navigation HOME CONTACT ABOUT PRODUCT PIPELINE RESOURCES PARTNERING INVESTORS MEDIA CAREERS Investors At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information. Recent News 11/16/21 Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease Non-Motor Symptoms 11/08/21 Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results 11/02/21 Acadia Pharmaceuticals Presents New Dementia-Related Psychosis Real-World Outcomes Data at Psych Congress 2021 2020 | 2019 | 2018 | Archive Webcasts Click here for webcast Webcast Q3 2021 ACADIA Pharmaceuticals Earnings Conference Call 11/08/21 at 4:30 PM EST Stock Quote Exchange Price Change (%) Volume 11/26/21 1:23 am EST Data Provided by Refinitiv. Minimum 15 minutes delayed. Refresh quote Data Provided by Refinitiv. Minimum 15 minutes delayed. Investor Relations INVESTORS STOCK INFORMATION NEWS RELEASES EVENTS & PRESENTATIONS SEC FILINGS CORPORATE GOVERNANCE FINANCIAL INFORMATION ANALYST COVERAGE ANNUAL REPORT AND PROXY INFORMATION REQUEST EMAIL ALERTS INVESTOR CONTACT Shareholder Tools Print Page RSS Feeds Share PRIVACY COOKIES PRIVACY SHIELD TERMS EMAIL © 2021 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered trademarks of Acadia Pharmaceuticals Inc. All rights reserved. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.